Clinica Chimica Acta SCIE

國際簡稱：CLIN CHIM ACTA 參考譯名：Acta 化學(xué)診所

主要研究方向：醫(yī)學(xué)-醫(yī)學(xué)實驗技術(shù) 非預(yù)警期刊審稿周期：約3.0個月約5.2周

《Acta 化學(xué)診所》(Clinica Chimica Acta)是一本由Elsevier出版的以醫(yī)學(xué)-醫(yī)學(xué)實驗技術(shù)為研究特色的國際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評論文章和綜述文章，及時報道該領(lǐng)域相關(guān)理論、實踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本未開放期刊，近三年沒有被列入預(yù)警名單。

3區(qū) 中科院分區(qū)
Q2 JCR分區(qū)
327 年發(fā)文量
3.2 IF影響因子
未開放 是否OA
127 H-index
1956 創(chuàng)刊年份
Monthly 出版周期
English 出版語言

The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)

Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.

The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal's scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.

[ 查看全部 ]

投稿咨詢加急咨詢

Clinica Chimica Acta期刊信息

ISSN：0009-8981
出版語言：English
是否OA：未開放
E-ISSN：1873-3492
出版地區(qū)：NETHERLANDS
是否預(yù)警：否
出版商：Elsevier
出版周期：Monthly
創(chuàng)刊時間：1956
開源占比：0.0813
Gold OA文章占比：16.95%
OA被引用占比：0.0316...
出版國人文章占比：0.19
出版撤稿占比：0
研究類文章占比：91.13%

Clinica Chimica Acta CiteScore評價數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

10.1

1.016

1.086

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：Biochemistry (medical)	Q1	10 / 72	86%
大類：Medicine 小類：Biochemistry	Q1	60 / 438	86%
大類：Medicine 小類：Clinical Biochemistry	Q1	18 / 117	85%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個指標(biāo)。當(dāng)年CiteScore 的計算依據(jù)是期刊最近4年（含計算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻數(shù)。例如，2022年的 CiteScore 計算方法為：2022年的 CiteScore =2019-2022年收到的對2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻數(shù)量注：文獻類型包括：文章、評論、會議論文、書籍章節(jié)和數(shù)據(jù)論文。

Clinica Chimica Acta中科院評價數(shù)據(jù)

中科院 2023年12月升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	MEDICAL LABORATORY TECHNOLOGY 醫(yī)學(xué)實驗技術(shù)	3區(qū)

中科院 2022年12月升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	MEDICAL LABORATORY TECHNOLOGY 醫(yī)學(xué)實驗技術(shù)	2區(qū)

中科院 2021年12月舊的升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	MEDICAL LABORATORY TECHNOLOGY 醫(yī)學(xué)實驗技術(shù)	3區(qū)

中科院 2021年12月基礎(chǔ)版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	MEDICAL LABORATORY TECHNOLOGY 醫(yī)學(xué)實驗技術(shù)	2區(qū)

中科院 2021年12月升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	3區(qū)	MEDICAL LABORATORY TECHNOLOGY 醫(yī)學(xué)實驗技術(shù)	3區(qū)

中科院 2020年12月舊的升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
否	否	醫(yī)學(xué)	4區(qū)	MEDICAL LABORATORY TECHNOLOGY 醫(yī)學(xué)實驗技術(shù)	3區(qū)

Clinica Chimica Acta JCR評價數(shù)據(jù)（2023-2024年最新版）

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：MEDICAL LABORATORY TECHNOLOGY	SCIE	Q2	9 / 30	71.7%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：MEDICAL LABORATORY TECHNOLOGY	SCIE	Q1	7 / 30	78.33%

Clinica Chimica Acta歷年數(shù)據(jù)統(tǒng)計

影響因子

中科院分區(qū)

Clinica Chimica Acta中國學(xué)者發(fā)文選摘

1、A rapid multiplex assay of human malaria parasites by digital PCR
Author: Dong, Liu; Li, Weijia; Xu, Qianqian; Gu, Jianfei; Kang, Zhihua; Chen, Jian; Xu, Xiao; Zhang, Xinju; Zhang, Xiuming; Jiang, Haoqin; Guan, Ming

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 539, Issue , pp. 70-78. DOI: 10.1016/j.cca.2022.12.001
2、The value of lipid metabolites 9,10-DOA and 11,12-EET in prenatal diagnosis of fetal heart defects
Author: Fang, Yiwei; Zhang, Zheng; Zhao, Yun; Sun, Guoqiang; Peng, Meilin; Liu, Chunyan; Yi, Guilin; Zhao, Kai; Yang, Hui

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 544, Issue , pp. -. DOI: 10.1016/j.cca.2023.117330
3、Biomarkers for chemotherapy and drug resistance in the mismatch repair pathway
Author: Dong, Liu; Jiang, Haoqin; Kang, Zhihua; Guan, Ming

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 544, Issue , pp. -. DOI: 10.1016/j.cca.2023.117338
4、Long noncoding RNA HAND2-AS1: A crucial regulator of malignancy
Author: Huang, Ziyue; Wang, Zhensheng; Xia, Haoming; Ge, Ziqiang; Yu, Liang; Li, Jiehan; Bao, Haolin; Liang, Zixin; Cui, Yunfu; Xu, Yi

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 539, Issue , pp. 162-169. DOI: 10.1016/j.cca.2022.12.010
5、Diagnostic potential of site-specific serotransferrin N-glycosylation in discriminating different liver diseases
Author: Zhang, Jiyun; Lai, Zhizhen; Ding, Rui; Zhou, Jinyu; Yuan, Zhonghao; Li, Dan; Qin, Xuzhen; Zhou, Jiang; li, Zhili

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 539, Issue , pp. 175-183. DOI: 10.1016/j.cca.2022.12.015
6、Fibrinogen beta chain may be a potential predict biomarker for pre-eclampsia: A preliminary study
Author: Shi, Junzhu; Zeng, Shanshui; Zhang, Yonggang; Zuo, Zhihua; Tan, Xiaoyu

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 539, Issue , pp. 206-214. DOI: 10.1016/j.cca.2022.12.012
7、Evaluating the value of anti-SARS-CoV-2 antibody detection and neutralizing responses with euvirus: A population of 10776 close contacts in the epidemic of Fujian
Author: Zeng, Yongbin; Lin, Caorui; Liu, Can; Huang, Chun; Chen, Falin; Cao, Yingping; Wu, Siying; Wei, Donghong; Lin, Zhong; Zhang, Yali; Zhang, Ling; Teng, Jing; Li, Zishun; Hong, Guolin; Yang, Tianci; Ye, Huiming; Tu, Haijian; Xiao, Yupeng; Huang, Lishan; Zhang, Jiawei; Chen, Tianbin; Li, Jinming; Ji, Fusui; Ou, Qishui

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 539, Issue , pp. 237-243. DOI: 10.1016/j.cca.2022.12.017
8、Intrafollicular fluid metabolic abnormalities in relation to ovarian hyperstimulation syndrome: Follicular fluid metabolomics via gas chromatography-mass spectrometry
Author: Sun, Yixuan; Hao, Lijuan; Han, Wei; Luo, Jing; Zheng, Jing; Yuan, Dong; Ye, Hong; Li, Qinke; Huang, Guoning; Han, Tingli; Yang, Zhu

Journal: CLINICA CHIMICA ACTA. 2023; Vol. 538, Issue , pp. 189-202. DOI: 10.1016/j.cca.2022.11.033